353810 — Easy Bio Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousSmall CapSuper Stock

Annual income statement for Easy Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Revenue
Total Revenue	88,123	129,458	155,557	165,385
Cost of Revenue
Gross Profit	29,663	40,631	47,283	52,018
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Total Operating Expenses	72,925	112,678	139,404	144,754
Operating Profit	15,198	16,779	16,153	20,631
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	13,369	14,054	11,984	20,066
Provision for Income Taxes
Net Income After Taxes	10,425	10,842	9,347	16,101
Minority Interest
Net Income Before Extraordinary Items
Net Income	10,425	10,873	9,131	15,544
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	10,425	10,873	9,131	15,544
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	305	318	267	455
Dividends per Share